We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Single Vial Transport for Intestinal Parasites Launched

By LabMedica International staff writers
Posted on 17 Jun 2015
Print article
Image: Trichuris trichiura (whipworm) ova from a stool specimen (Photo courtesy of the US Centers for Disease Control and Prevention).
Image: Trichuris trichiura (whipworm) ova from a stool specimen (Photo courtesy of the US Centers for Disease Control and Prevention).
A one-vial, multipurpose, transport solution for the collection, transportation, preservation and examination of intestinal parasites in stool specimens has been launched.

Traditional ova and parasite examination procedures, as well as fecal antigen immunoassay tests, require different types of preservatives/transports to run a complete parasitological examination.

The new transport medium allows laboratorians to perform all of the testing from one vial, a significant improvement over multi-vial systems. Stool specimens preserved in Para-Pak SVT (Meridian Bioscience, Inc.; Cincinnati, OH, USA) can be used for direct examination, concentration, permanent stain and will not interfere with fecal immunoassays. The new Para-Pak SVT (Single Vial Transport) is also mercury, polyvinyl-alcohol (PVA) and formalin free, a more eco-friendly alternative for the laboratories when it comes to handling and disposal. As experts in parasitology and leaders in pre-analytic collection systems, including stool collection and transport systems, Meridian Bioscience continues to develop innovative products that meet the needs of today's healthcare providers.

Michael C. Shaughnessy, Executive Vice President and President Meridian Global Diagnostics, said, “Over 20,000,000 stool transport systems are used in the USA annually and the development of Para-Pak SVT provides a simplified solution for healthcare providers by offering a one patient–one transport vial approach that helps reduce potential errors associated with traditional multi-vial systems, and also offers improved work-flow options for laboratories. This is a single transport system that is cost effective and adds testing flexibility to the lab, allowing them to perform from ova and parasite (O&P) examination and fecal immunoassays from one vial.”

Related Links:

Meridian Bioscience, Inc. 


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System
New
Amoebiasis Test
ELI.H.A Amoeba

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.